Effect of Preventive and Curative Fingolimod Treatment Regimens on Microglia Activation and Disease Progression in a Rat Model of Multiple Sclerosis.

about

Effect of Preventive and Curative Fingolimod Treatment Regimens on Microglia Activation and Disease Progression in a Rat Model of Multiple Sclerosis.

Item

http://www.wikidata.org/entity/Q41125322

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Effect of Preventive and Curat ...... t Model of Multiple Sclerosis.

@en

type

Item

label

Effect of Preventive and Curat ...... t Model of Multiple Sclerosis.

@en

prefLabel

Effect of Preventive and Curat ...... t Model of Multiple Sclerosis.

@en

P1476

Effect of Preventive and Curat ...... t Model of Multiple Sclerosis.

@en

P2093

Janine Doorduin

http://www.w3.org/2001/XMLSchema#string

Rudi A J O Dierckx

http://www.w3.org/2001/XMLSchema#string

P2860

Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function

(11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

Fast and accurate modelling of longitudinal and repeated measures neuroimaging data.

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.

Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis.

Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis.

Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model.

Fingolimod modulates microglial activation to augment markers of remyelination.

P2888

s11481-017-9741-x

P304

521-530

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11481-017-9741-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David Vállez García

D de Paula Faria

E F J de Vries

P577

2017-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28361437

http://www.w3.org/2001/XMLSchema#string

P921

microglia

P932

5527053

http://www.w3.org/2001/XMLSchema#string